Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 275, Issue 1 38-1, 1998, Pages

  Lewis, Gary F ^a,b   Vranic, Mladen ^a   Giacca, Adria ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Glucose clamp technique; Portal vein; Tolbutamide

Indexed keywords

FATTY ACID; GLUCAGON; INSULIN; TOLBUTAMIDE;

ADULT; ARTICLE; FATTY ACID METABOLISM; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; LIPOLYSIS; MALE; NORMAL HUMAN; PORTAL VEIN; PRIORITY JOURNAL; SUBSTITUTION THERAPY;

EID: 0031830758     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.275.1.e177     Document Type: Article

References (30)

1. Ader, M., and R. N. Bergman. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E1020-E1032, 1990.
2. Boden, G., X. Chen, R. A. Desantis, and Z. Kendrick. Effects of insulin on fatty acid reesterification in healthy subjects. Diabetes 42: 1588-1593, 1993.
3. Bradley, D. C., G. M. Steil, and R. N. Bergman. Quantitation of measurement error with Optimal Segments: basis for adaptive time course smoothing. Am. J. Physiol. 264 (Endocrinol. Metab. 27): E902-E911, 1993.
4. Campra, J. L., and T. B. Reynolds. The hepatic circulation. In: The Liver. Biology and Pathobiology, edited by I. M. Arias, H. Popper, D. Schachter, and D. A. Shafritz. New York: Raven, 1982, p. 627-645.
5. De Feo, P., G. Perriello, S. De Cosmo, M. M. Ventura, P. J. Campbell, P. Brunetti, J. E. Gerich, and G. B. Bolli. Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans. Diabetes 35: 563-569, 1986.
6. Faber, O. K., C. Binder, J. Markussen, L. G. Heding, V. K. Naithani, H. Kuzuya, P. Blix, D. L. Horwitz, and A. H. Rubenstein. Characterization of seven C-peptide antisera. Diabetes 27, Suppl. 1: 170-177, 1978.
7. Fanelli, C., S. Calderone, L. Epifano, A. De Vincenzo, F. Modarelli, S. Pampanelli, G. Perriello, P. De Feo, P. Brunetti, J. E. Gerich, and G. B. Bolli. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J. Clin. Invest. 92: 1617-1622, 1993.
8. Finegood, D. T., and R. N. Bergman. Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes. Am. J. Physiol. 244 (Endocrinol. Metab. 7): E472-E479, 1983.
9. Finegood, D. T., R. N. Bergman, and M. Vranic. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36: 914-924, 1987.
10. Finegood, D. T., R. N. Bergman, and M. Vranic. Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37: 1025-1034, 1988.
11. Garner, C. W. Boronic acid inhibitors of porcine pancreatic lipase. J. Biol. Chem. 255: 5064-5068, 1980.
12. Giacca, A., S. J. Fisher, R. H. McCall, Z. Q. Shi, and M. Vranic. Direct and indirect effects of insulin in suppressing glucose production in depancreatised dogs: role of glucagon. Endocrinology 138: 999-1007, 1997.
13. Giacca, A., S. J. Fisher, Z. Q. Shi, R. Gupta, H. L. Lickley, and M. Vranic. Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J. Clin. Invest. 90: 1769-1777, 1992.
14. Lewis, G. F., G. Steiner, K. S. Polonsky, B. Weller, and B. Zinman. A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion. J. Clin. Endocrinol. Metab. 79: 66-70, 1994.
15. Lewis, G. F., M. Vranic, and A. Giacca. Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E371-E378, 1997.
16. Lewis, G. F., M. Vranic, P. Harley, and A. Giacca. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 46: 1111-1119, 1997.
17. Lewis, G. F., B. Zinman, Y. Groenewoud, M. Vranic, and A. Giacca. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45: 454-462, 1996.
18. Lewis, G. F., B. Zinman, K. D. Uffelman, L. Szeto, B. Weller, and G. Steiner. VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E566-E572, 1994.
19. Mittelman, S., Y. Y. Fu, K. Rebrin, G. Steil, and R. N. Bergman. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J. Clin. Invest. 100: 3121-3130, 1997.
20. Prager, R., P. Wallace, and J. M. Olefsky. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 36: 607-611, 1987.
21. Randle, P. J., P. B. Garland, C. N. Hales, and E. A. Newsholme. The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
22. Rebrin, K., G. M. Steil, L. Getty, and R. N. Bergman. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44: 1038-1045, 1995.
23. Rebrin, K., G. M. Steil, S. D. Mittelman, and R. N. Bergman. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J. Clin. Invest. 98: 741-749, 1996.
24. Saloranta, C., M. R. Taskinen, E. Widen, M. Harkonen, A. Melander, and L. Groop. Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM. Diabetes 42: 1559-1566, 1993.
25. 3H]glucose. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E228-E233, 1990.
26. Shi, Z. Q., D. Wasserman, and M. Vranic. Metabolic implications of exercise and physical fitness in physiology and diabetes. In: Ellenberg and Rifkin Diabetes Mellitus, edited by D. Porte and R. Sherwin. Norwolk, CT: Appleton and Lange, 1997, p. 653-687.
27. Sindelar, D. K., J. H. Balcom, C. A. Chu, D. W. Neal, and A. D. Cherrington. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes 45: 1594-1604, 1996.
28. Sindelar, D. K., C. Chu, M. Rohlie, D. W. Neal, L. L. Swift, and A. D. Cherrington. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46: 187-196, 1997.
29. Stumvoll, M., C. Meyer, A. Mitrakou, V. Nadkarni, and J. E. Gerich. Renal glucose production and utilization: new aspects in humans. Diabetologia 40: 749-757, 1997.
30. Van Cauter, E., F. Mestrez, J. Sturis, and K. S. Polonsky. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41: 368-377, 1992.